BofA raised the firm’s price target on Nutrien (NTR) to $71 from $64 and keeps a Neutral rating on the shares. The backdrop of a nutrient market where pricing is holding in stronger for longer is driving the firm’s estimates higher, but over the medium term the firm remains “a bit skeptical on how durable this view is given rising potash supply,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
